CGEM

Cullinan Therapeutics, Inc.

HealthcareMedical - PharmaceuticalsUSUSDPeers →

$17.65

LiveJun 24, 2026

Market cap

$1.08B

52w range

5.68 – 18.76

P / E

—

EPS

—

Volume

1.44M

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Cullinan Therapeutics, Inc.’s valuation

○

Insider buys and sells are sourced from SEC Form 4 filings, which cover US-listed issuers. We don't have Form 4 history for this name.

Transactions

0 buys · 0 sells

Bought

Open market

Sold

Open market

Net flow

+$0

Buys − sells

Insider	Role	Action	Shares	Price	Value	Trade date	Filing
No open-market insider activity in this window.

13F position evolution

No 13F history in institutional_holders for CGEM-US.

Pro

Detailed insider buy/sell history is included with Pro.